Skip to main content
Equibles

NEA Management Company, LLC

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1512848 TIMONIUM, MD
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,101,579
+$1,746,221 QoQ
Shares Held
3,233,743
0.0% QoQ
Ownership
3.26%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#11
of 89 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. XFOR ranks #13 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TRVI
Trevi Therapeutics, Inc.
 13,222,228 $246,594,552
2 MBX
MBX Biosciences, Inc.
 3,614,486 $199,519,627
3 GLUE
Monte Rosa Therapeutics, Inc.
 7,692,298 $186,153,611
4 CELC
Celcuity Inc.
 1,710,561 $178,958,891
5 SGP
SpyGlass Pharma, Inc.
 7,392,301 $164,552,620
6 SVRA
Savara Inc
 24,471,264 $150,742,986
7 ZBIO
Zenas BioPharma, Inc.
 4,023,219 $102,109,298
8 AUPH
Aurinia Pharmaceuticals Inc.
 3,969,834 $67,368,082

All Filings in XFOR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,101,579 3,233,743
2026-03-31 $13,355,358 3,233,743
2025-12-31 $12,934,972 3,233,743
2025-09-30 $7,639,401 2,233,743
2025-06-30 $949,162 499,559
2025-03-31 $3,536,883 14,986,793
2024-12-31 $11,000,306 14,986,793
2024-09-30 $10,026,164 14,986,793
2024-06-30 $8,692,339 14,986,793
2024-03-31 $20,831,642 14,986,793
2023-12-31 $12,573,919 14,986,793
2023-09-30 $16,335,604 14,986,793
2023-06-30 $29,074,378 14,986,793
2023-03-31 $10,211,009 11,736,793
2022-12-31 $11,654,635 11,736,793
2022-09-30 $11,154,598 6,523,157
2020-03-31 $3,333,329 333,333